Standout Papers
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2 (2001)
- Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease (1999)
Immediate Impact
5 by Nobel laureates 15 from Science/Nature 189 standout
Citing Papers
Deciphering breast cancer: from biology to the clinic
2023 Standout
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
Works of Janet Wolter being referenced
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
1999 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Janet Wolter | 9010 | 2290 | 1252 | 4023 | 3205 | 30 | 12.1k | |
| Virginia Paton | 9754 | 2552 | 513 | 4546 | 3446 | 30 | 13.1k | |
| Steven Wong | 11375 | 1924 | 1260 | 6484 | 6542 | 35 | 15.8k | |
| Wendy J. Levin | 11356 | 1925 | 1286 | 6484 | 6403 | 36 | 15.5k | |
| Tadeusz Pieńkowski | 9343 | 2438 | 1041 | 3176 | 1963 | 129 | 11.6k | |
| Alex Bajamonde | 6655 | 1756 | 431 | 3000 | 2870 | 7 | 9.5k | |
| Patrick Therasse | 10686 | 8536 | 865 | 3223 | 3592 | 36 | 20.2k | |
| Kimberly Blackwell | 5876 | 2367 | 632 | 1900 | 2095 | 139 | 8.9k | |
| Graham Ross | 7823 | 2140 | 165 | 2831 | 2261 | 42 | 9.0k | |
| Silvana Martino | 9051 | 2157 | 3008 | 1397 | 1990 | 124 | 12.6k | |
| David Miles | 5878 | 2119 | 285 | 2655 | 2176 | 92 | 8.2k |
All Works
Loading papers...